Form 8-K - Current report:
SEC Accession No. 0001213900-25-056909
Filing Date
2025-06-24
Accepted
2025-06-24 07:45:13
Documents
50
Period of Report
2025-06-24
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0246672-8k_nektar.htm   iXBRL 8-K 68256
2 PRESS RELEASE ISSUED BY NEKTAR THERAPEUTICS ON JUNE 24, 2025, FURNISHED HEREWITH ea024667201ex99-1_nektar.htm EX-99.1 52221
3 NEKTAR THERAPEUTICS CORPORATE PRESENTATION, FURNISHED HEREWITH ea024667201ex99-2_nektar.htm EX-99.2 68081
4 GRAPHIC ex99-1_001.jpg GRAPHIC 2044
5 GRAPHIC ex99-2_001.jpg GRAPHIC 207827
6 GRAPHIC ex99-2_002.jpg GRAPHIC 590252
7 GRAPHIC ex99-2_003.jpg GRAPHIC 292188
8 GRAPHIC ex99-2_004.jpg GRAPHIC 276531
9 GRAPHIC ex99-2_005.jpg GRAPHIC 368939
10 GRAPHIC ex99-2_006.jpg GRAPHIC 217459
11 GRAPHIC ex99-2_007.jpg GRAPHIC 257304
12 GRAPHIC ex99-2_008.jpg GRAPHIC 190803
13 GRAPHIC ex99-2_009.jpg GRAPHIC 212795
14 GRAPHIC ex99-2_010.jpg GRAPHIC 198287
15 GRAPHIC ex99-2_011.jpg GRAPHIC 231330
16 GRAPHIC ex99-2_012.jpg GRAPHIC 235272
17 GRAPHIC ex99-2_013.jpg GRAPHIC 241155
18 GRAPHIC ex99-2_014.jpg GRAPHIC 273735
19 GRAPHIC ex99-2_015.jpg GRAPHIC 228617
20 GRAPHIC ex99-2_016.jpg GRAPHIC 351029
21 GRAPHIC ex99-2_017.jpg GRAPHIC 216994
22 GRAPHIC ex99-2_018.jpg GRAPHIC 245173
23 GRAPHIC ex99-2_019.jpg GRAPHIC 242373
24 GRAPHIC ex99-2_020.jpg GRAPHIC 384686
25 GRAPHIC ex99-2_021.jpg GRAPHIC 336638
26 GRAPHIC ex99-2_022.jpg GRAPHIC 173671
27 GRAPHIC ex99-2_023.jpg GRAPHIC 229486
28 GRAPHIC ex99-2_024.jpg GRAPHIC 190182
29 GRAPHIC ex99-2_025.jpg GRAPHIC 251469
30 GRAPHIC ex99-2_026.jpg GRAPHIC 264532
31 GRAPHIC ex99-2_027.jpg GRAPHIC 257364
32 GRAPHIC ex99-2_028.jpg GRAPHIC 182305
33 GRAPHIC ex99-2_029.jpg GRAPHIC 305087
34 GRAPHIC ex99-2_030.jpg GRAPHIC 386040
35 GRAPHIC ex99-2_031.jpg GRAPHIC 438780
36 GRAPHIC ex99-2_032.jpg GRAPHIC 329707
37 GRAPHIC ex99-2_033.jpg GRAPHIC 327800
38 GRAPHIC ex99-2_034.jpg GRAPHIC 325269
39 GRAPHIC ex99-2_035.jpg GRAPHIC 306225
  Complete submission text file 0001213900-25-056909.txt   13847121

Data Files

Seq Description Document Type Size
40 XBRL SCHEMA FILE nktr-20250624.xsd EX-101.SCH 3008
41 XBRL LABEL FILE nktr-20250624_lab.xml EX-101.LAB 34239
42 XBRL PRESENTATION FILE nktr-20250624_pre.xml EX-101.PRE 22354
52 EXTRACTED XBRL INSTANCE DOCUMENT ea0246672-8k_nektar_htm.xml XML 3565
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 251066696
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)